Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1332

Title:	Long-Term Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Solid Organ Transplant or Allogeneic Hematopoietic Cell Transplant Treated with Tabelecleucel in a Multicenter Expanded Access Program Study
Authors:	Prockop, S. E. Reshef, R. Tsai, D. E. Bunin, N. Abu-Arja, R. Mahadeo, K. M. Wen-Kai Weng van Besien, K. Loeb, D. Nasta, S. D. Nemecek, E. R. Hiremath, M. Yue, S. Sun, Y. Navarro, W. H. Nikiforow, S.
Issue Date:	Mar-2020
Journal Volume:	26
Journal Issue:	3
Source:	Biology of Blood and Marrow Transplantation
URI:	http://scholars.ntou.edu.tw/handle/123456789/1332
ISSN:	1083-8791
DOI:	://WOS:000516887900082
Appears in Collections:	河海工程學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS